سعر التراجريزوفلفين Ultragriseofulvin‏ 2.5جم/100مل معلق 100 مل 2026

Ultragriseofulvin oral suspension: griseofulvin 2.5 g/100 ml (125 mg/5 ml), 100 ml bottle; systemic antifungal by Kahira Pharmaceuticals.

• Hypersensitivity reactions such as skin rashes and urticaria; rarely angioneurotic edema, erythema multiforme-like eruptions; also oral thrush, nausea, vomiting, epigastric distress, diarrhea, headache, fatigue, dizziness, insomnia, mental confusion; rarely proteinuria and leukopenia (discontinue if granulocytopenia occurs).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnancy (griseofulvin may cause fetal harm; rare reports of conjoined twins).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Contraindicated in patients with porphyria or hepatocellular failure, and in patients with a history of hypersensitivity to griseofulvin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Severe skin reactions (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis) and erythema multiforme have been reported; discontinue if they occur.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hepatotoxicity (elevated AST/ALT, bilirubin, jaundice) has been reported; monitor and discontinue as appropriate.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Possible cross-sensitivity with penicillins (griseofulvin is a Penicillium derivative); photosensitivity reactions may occur and lupus erythematosus or lupus-like syndromes may be aggravated.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Warfarin-type anticoagulantsGriseofulvin decreases the activity of warfarin-type anticoagulants; dosage adjustment of the anticoagulant may be needed during and after griseofulvin therapy.DailyMed (U.S. National Library of Medicine)
• BarbituratesBarbiturates usually depress griseofulvin activity; concomitant use may require a dosage adjustment of the antifungal.DailyMed (U.S. National Library of Medicine)
• Oral contraceptivesGriseofulvin may reduce the efficacy of oral contraceptives and increase breakthrough bleeding.DailyMed (U.S. National Library of Medicine)

• Contraindicated in women who are pregnant; griseofulvin may cause fetal harm.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)